Reviews |
From the Department of Pharmacology, University of Nevada School of Medicine, Reno.
Correspondence to William T. Gerthoffer, Department of Pharmacology, University of Nevada School of Medicine, Reno, NV 89557. E-mail wtg{at}med.unr.edu
This Review is part of a thematic series on Migration of Vascular Cells, which includes the following articles:
Mechanisms of Vascular Smooth Muscle Cell Migration
Endothelial Cell Migration During Angiogenesis
Leukocyte Migration in the Vascular Wall
Molecular Mechanisms of Endothelial Cell Migration
Endothelial Migration in Vascular Development
Kathy K. Griendling Editor
Smooth muscle cell migration occurs during vascular development, in response to vascular injury, and during atherogenesis. Many proximal signals and signal transduction pathways activated during migration have been identified, as well as components of the cellular machinery that affect cell movement. In this review, a summary of promigratory and antimigratory molecules belonging to diverse chemical and functional families is presented, along with a summary of key signaling events mediating migration. Extracellular molecules that modulate migration include small biogenic amines, peptide growth factors, cytokines, extracellular matrix components, and drugs used in cardiovascular medicine. Promigratory stimuli activate signal transduction cascades that trigger remodeling of the cytoskeleton, change the adhesiveness of the cell to the matrix, and activate motor proteins. This review focuses on the signaling pathways and effector proteins regulated by promigratory and antimigratory molecules. Prominent pathways include phosphatidylinositol 3-kinases, calcium-dependent protein kinases, Rho-activated protein kinase, p21-activated protein kinases, LIM kinase, and mitogen-activated protein kinases. Important downstream targets include myosin II motors, actin capping and severing proteins, formins, profilin, cofilin, and the actin-related protein-2/3 complex. Actin filament remodeling, focal contact remodeling, and molecular motors are coordinated to cause cells to migrate along gradients of chemical cues, matrix adhesiveness, or matrix stiffness. The result is recruitment of cells to areas where the vessel wall is being remodeled. Vessel wall remodeling can be antagonized by common cardiovascular drugs that act in part by inhibiting vascular smooth muscle cell migration. Several therapeutically important drugs act by inhibiting cell cycle progression, which may reduce the population of migrating cells.
Key Words: actin cytoskeletal dynamics growth factors signal transduction vascular smooth muscle cells
This article has been cited by other articles:
![]() |
D. D. Tang p130 Crk-Associated Substrate (CAS) in Vascular Smooth Muscle Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 89 - 98. [Abstract] [PDF] |
||||
![]() |
L. Wang, J. Zheng, X. Bai, B. Liu, C.-j. Liu, Q. Xu, Y. Zhu, N. Wang, W. Kong, and X. Wang ADAMTS-7 Mediates Vascular Smooth Muscle Cell Migration and Neointima Formation in Balloon-Injured Rat Arteries Circ. Res., March 13, 2009; 104(5): 688 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, K. Kimura, H. Shirai, K. Eguchi, S. Higuchi, A. Hinoki, K. Ishimaru, E. Brailoiu, D. N. Dhanasekaran, L. N. Stemmle, et al. Endothelial Nitric Oxide Synthase Inhibits G12/13 and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor: Implication in Vascular Migration Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rodriguez-Menocal, M. St-Pierre, Y. Wei, S. Khan, D. Mateu, M. Calfa, A. A. Rahnemai-Azar, G. Striker, S. M. Pham, and R. I. Vazquez-Padron The origin of post-injury neointimal cells in the rat balloon injury model Cardiovasc Res, January 1, 2009; 81(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tada, J. Nawata, H. Wang, N. Onoue, D. Zhulanqiqige, K. Ito, K. Sugimura, Y. Fukumoto, and H. Shimokawa Enhanced pulsatile pressure accelerates vascular smooth muscle migration: implications for atherogenesis of hypertension Cardiovasc Res, December 1, 2008; 80(3): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meng, D.-D. Lv, and J. Fang Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells Cardiovasc Res, November 1, 2008; 80(2): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Yokoyama, S. Minamisawa, H. Quan, T. Akaike, S. Suzuki, M. Jin, Q. Jiao, M. Watanabe, K. Otsu, S. Iwasaki, et al. Prostaglandin E2-activated Epac Promotes Neointimal Formation of the Rat Ductus Arteriosus by a Process Distinct from That of cAMP-dependent Protein Kinase A J. Biol. Chem., October 17, 2008; 283(42): 28702 - 28709. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Fuller and D. J. Benos Putting the brakes on vascular smooth muscle cell migration Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1987 - H1988. [Full Text] [PDF] |
||||
![]() |
A. San Martin, M. Y. Lee, H. C. Williams, K. Mizuno, B. Lassegue, and K. K. Griendling Dual Regulation of Cofilin Activity by LIM Kinase and Slingshot-1L Phosphatase Controls Platelet-Derived Growth Factor-Induced Migration of Human Aortic Smooth Muscle Cells Circ. Res., February 29, 2008; 102(4): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayashi, O. Aharonovitz, R. T. Alexander, N. Touret, W. Furuya, J. Orlowski, and S. Grinstein Na+/H+ exchange and pH regulation in the control of neutrophil chemokinesis and chemotaxis Am J Physiol Cell Physiol, February 1, 2008; 294(2): C526 - C534. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Gerthoffer Migration of Airway Smooth Muscle Cells Proceedings of the ATS, January 1, 2008; 5(1): 97 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zeidan, B. Paylor, K. J. Steinhoff, S. Javadov, V. Rajapurohitam, S. Chakrabarti, and M. Karmazyn Actin Cytoskeleton Dynamics Promotes Leptin-Induced Vascular Smooth Muscle Hypertrophy via RhoA/ROCK- and Phosphatidylinositol 3-Kinase/Protein Kinase B-Dependent Pathways J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1110 - 1116. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |